HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoya Masumori Selected Research

Sex Reassignment Surgery

1/2016SEX REASSIGNMENT SURGERY WITH LAPAROSCOPIC SIGMOID COLON VAGINOPLASTY IN A MALE TO FEMALE TRANSSEXUAL: A CASE REPORT.
6/2014Risk factors for the development of well leg compartment syndrome after sex reassignment surgery in patients with gender identity disorder.
5/2012Status of sex reassignment surgery for gender identity disorder in Japan.
5/2010[Surgical treatment for gender identity disorder 1. Sex reassignment surgery for male to female].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoya Masumori Research Topics

Disease

67Neoplasms (Cancer)
04/2022 - 02/2002
52Prostatic Neoplasms (Prostate Cancer)
07/2021 - 02/2002
36Renal Cell Carcinoma (Grawitz Tumor)
04/2022 - 01/2002
30Neoplasm Metastasis (Metastasis)
04/2022 - 05/2003
30Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 06/2004
26Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2019 - 06/2002
17Overactive Urinary Bladder (Overactive Bladder)
03/2022 - 01/2010
16Carcinoma (Carcinomatosis)
01/2022 - 05/2003
14Lower Urinary Tract Symptoms
10/2018 - 11/2006
9Disease Progression
04/2022 - 07/2006
8Lymphatic Metastasis
06/2021 - 11/2002
7Interstitial Cystitis (Interstitial Cystitis, Chronic)
11/2021 - 10/2006
7Gender Dysphoria
01/2021 - 05/2009
5Margins of Excision
06/2017 - 01/2008
5Surgical Wound Infection
02/2015 - 08/2007
4Urinary Incontinence
01/2021 - 03/2010
4Acute Kidney Injury (Acute Renal Failure)
05/2020 - 01/2016
4Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2020 - 06/2002
4Testicular Neoplasms (Testicular Cancer)
01/2018 - 06/2006
4Adenocarcinoma
01/2017 - 08/2011
3Edema (Dropsy)
11/2021 - 01/2017
3Hemorrhage
11/2021 - 04/2005
3Cystitis
08/2021 - 01/2017
3Fever (Fevers)
05/2021 - 08/2011
3Urinary Retention
03/2021 - 11/2018
3Bacteremia
05/2020 - 04/2015
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2018 - 06/2006
3Non-Muscle Invasive Bladder Neoplasms
07/2018 - 11/2014
3Insulin Resistance
11/2017 - 04/2007
3Infections
01/2017 - 10/2013
3Febrile Neutropenia
10/2015 - 08/2014
3Anorexia
10/2015 - 06/2011
3Abscess
02/2015 - 07/2007
3Neuroendocrine Carcinoma
04/2013 - 01/2004
3Residual Neoplasm
01/2011 - 02/2006
3Underactive Urinary Bladder
05/2010 - 11/2006

Drug/Important Bio-Agent (IBA)

17Prostate-Specific Antigen (Semenogelase)IBA
04/2021 - 08/2004
15AndrogensIBA
06/2021 - 01/2004
10Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2006
9Hormones (Hormone)IBA
01/2021 - 01/2004
8Sunitinib (Sutent)FDA Link
04/2022 - 06/2013
8Tamsulosin (Flomax)FDA LinkGeneric
11/2018 - 11/2005
6GemcitabineFDA Link
01/2022 - 03/2008
5NivolumabIBA
04/2022 - 05/2020
5Axitinib (AG 013736)IBA
04/2022 - 11/2018
5Radium-223IBA
04/2021 - 02/2018
5Testosterone (Sustanon)FDA Link
01/2019 - 06/2004
5Cholinergic Antagonists (Anticholinergics)IBA
05/2018 - 01/2011
5naftopidilIBA
01/2016 - 11/2005
4N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
03/2022 - 01/2019
4Biomarkers (Surrogate Marker)IBA
10/2021 - 06/2013
4Pharmaceutical PreparationsIBA
08/2021 - 06/2013
4Androgen Receptors (Androgen Receptor)IBA
04/2021 - 01/2004
4SteroidsIBA
02/2021 - 11/2017
4Tyrosine Kinase InhibitorsIBA
11/2020 - 08/2014
4C-Reactive ProteinIBA
10/2019 - 02/2010
4Dutasteride (Avodart)FDA Link
09/2019 - 03/2011
4silodosinFDA Link
10/2018 - 09/2008
4Solifenacin SuccinateFDA Link
10/2016 - 01/2010
4IsoflavonesIBA
09/2016 - 08/2004
4Proteins (Proteins, Gene)FDA Link
01/2015 - 12/2008
3pazopanibFDA Link
04/2022 - 08/2014
3EverolimusFDA Link
04/2022 - 06/2013
3Aldehyde Dehydrogenase 1 FamilyIBA
01/2021 - 01/2013
3Sorafenib (BAY 43-9006)FDA Link
01/2020 - 12/2008
3CytokinesIBA
09/2019 - 06/2013
3propiverineIBA
05/2018 - 01/2011
3Etoposide (VP 16)FDA LinkGeneric
01/2018 - 02/2006
3CreatinineIBA
10/2017 - 04/2007
3Zoledronic Acid (Zometa)FDA Link
02/2017 - 04/2013
3EquolIBA
09/2016 - 01/2013
3GenisteinIBA
09/2016 - 08/2004
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2015 - 02/2006
3Interferon-alpha (Interferon Alfa)IBA
08/2014 - 12/2008
3imidafenacinIBA
10/2013 - 01/2011
3SurvivinIBA
01/2013 - 11/2009
3Androgen Antagonists (Antiandrogens)IBA
03/2011 - 06/2004
3AntigensIBA
12/2009 - 04/2007
3Tumor Viral Antigens (Large T Antigen)IBA
01/2004 - 05/2003

Therapy/Procedure

46Therapeutics
01/2022 - 08/2004
30Cystectomy
01/2022 - 06/2004
26Drug Therapy (Chemotherapy)
01/2022 - 02/2006
17Castration
06/2021 - 06/2004
13Nephrectomy
04/2022 - 01/2002
12Lymph Node Excision (Lymph Node Dissection)
11/2017 - 11/2002
10Prostatectomy (Retropubic Prostatectomy)
06/2017 - 05/2004
8Nephroureterectomy
06/2021 - 08/2007
7Urinary Diversion (Ileal Conduit)
01/2022 - 10/2004
7Radiotherapy
06/2021 - 05/2004
7Neoadjuvant Therapy
10/2019 - 08/2008
6Aftercare (After-Treatment)
01/2021 - 10/2006
5Operative Surgical Procedures
05/2020 - 09/2009
5Molecular Targeted Therapy
01/2020 - 06/2013
5Transurethral Resection of Prostate (TURP)
05/2010 - 02/2002
4Immunotherapy
04/2022 - 11/2008
4Intravesical Administration
01/2021 - 12/2006
4Sex Reassignment Surgery
01/2016 - 05/2010
3Urinary Catheters
03/2021 - 11/2010
3Conservative Treatment
05/2020 - 08/2011
3Renal Dialysis (Hemodialysis)
05/2020 - 03/2008